Anisha is a Clinical Consultant at LFH Regulatory. She completed her BSc (Hons) in Biomedical Science before pursuing an academic research pathway, culminating in a PhD in Life Science from the University of Hull (Hull York Medical School). She began her professional career in 2021 within a large medical device company, where she gained substantial experience developing clinical documentation to support regulatory submissions for medical devices spanning Class I to Class III as well as, Class A and B in vitro devices. She later joined a regulatory consultancy, further broadening her expertise in producing clinical evidence packages for a wide range of medical devices, including software as a medical device across multiple risk classes. Through these roles, she has built strong proficiency in MDR/IVDR clinical requirements, literature review methodologies, clinical evaluation strategy, and evidence generation planning.
Anisha is dedicated to supporting manufacturers in navigating the increasingly complex regulatory landscape, ensuring that clinical evidence is robust, compliant, and aligned with current international expectations. She strives to collaborate with clients to ensure the approval of safe, effective, and patient-focused medical technologies.